Immune responses in cystic fibrosis: are they intrinsically defective?
about
Infection, inflammation and exercise in cystic fibrosisIon channels and transporters in lymphocyte function and immunityToll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosisAspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapyThe impact of oil spill to lung health--Insights from an RNA-seq study of human airway epithelial cellsHeterozygosity for the F508del mutation in the cystic fibrosis transmembrane conductance regulator anion channel attenuates influenza severityReduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis.Reactive-oxygen-species-mediated P. aeruginosa killing is functional in human cystic fibrosis macrophages.Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patientsDefective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungsAlterations in blood leukocytes of G551D-bearing cystic fibrosis patients undergoing treatment with ivacaftor.Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.Pyocyanin effects on respiratory epithelium: relevance in Pseudomonas aeruginosa airway infections.Influenza matrix protein 2 alters CFTR expression and function through its ion channel activity.Cystic fibrosis transmembrane conductance regulator recruitment to phagosomes in neutrophils.The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infectionRole of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation.The challenges and promises of new therapies for cystic fibrosis.Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report.The art of persistence-the secrets to Burkholderia chronic infections.Macular pigment and macular volume in eyes of patients with cystic fibrosis.CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis.in Chronic Lung Infections: How to Adapt Within the Host?
P2860
Q21284416-D39A669A-7DD5-49B1-AA62-AF2CF37F7E7EQ26829714-5B76BF84-2235-4453-9AE5-C32FDC7D0B67Q27010697-E2223A2B-C86D-4642-8B48-E9B245EA60F8Q28074671-0D93B003-9049-4B74-A611-4F3C283CB324Q28392048-454BED9C-B909-42AA-8568-F8659A77FF55Q30431666-2A320817-C372-43C0-91D2-AC0F1E1DDC9CQ34309058-C6C66DF9-643D-4264-8E0C-828E759BFC91Q34971998-6EA54B89-864E-4A3C-9733-B86DE2D2EB87Q35151823-E821FC26-9BC0-4223-A322-CA357842A959Q35816416-CA5CA7D9-327B-41F0-A45C-FC33CEC76FB3Q36053155-C920EBC3-1202-45BC-B0E7-D784605DED49Q36112019-7F598D6B-0123-4352-A889-DD063C9AD596Q36142593-A1BA1D56-DC31-40F2-BACB-5FAA83F1E268Q36269787-D64590D2-7CF6-4083-A3B1-861DFDE7E116Q36589251-6FF0370E-895B-4E8D-A53D-A5D697D3C484Q36837735-0D739154-F826-49C1-AB80-69FDFBE4D2DFQ37029698-ED28D007-AEBE-40E7-AACA-CD43A2BEED6BQ37351609-201F3E62-076C-426B-AE61-7448E3317E96Q37478266-DF5A7694-2E15-4FC1-BEF8-57F4FD942E2CQ37631563-F535BAA6-F034-4D4B-9A0D-632759CC40BFQ38023386-DE4A2215-FD3B-4015-B71B-12F6F25B3C38Q38543069-C80A1067-106E-40F3-8E95-027751679622Q38839466-DA18FBCD-6DD1-4D27-A286-3D0554972C73Q39231679-EFC0FE36-6EB2-4980-88CB-163BCA0EAEECQ39284204-6DF42F92-2652-417A-92E5-987B51FFCCD0Q45198935-82195634-E82C-433B-B45B-47D691C077C0Q49216817-9ABD0920-9593-4CE8-8E7B-3865B7F5FADFQ58580408-E6823700-CEE7-4C4A-8C2D-B879CE30EF77
P2860
Immune responses in cystic fibrosis: are they intrinsically defective?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immune responses in cystic fibrosis: are they intrinsically defective?
@en
Immune responses in cystic fibrosis: are they intrinsically defective?
@nl
type
label
Immune responses in cystic fibrosis: are they intrinsically defective?
@en
Immune responses in cystic fibrosis: are they intrinsically defective?
@nl
prefLabel
Immune responses in cystic fibrosis: are they intrinsically defective?
@en
Immune responses in cystic fibrosis: are they intrinsically defective?
@nl
P2860
P356
P1476
Immune responses in cystic fibrosis: are they intrinsically defective?
@en
P2093
Christian Mueller
Dmitry Ratner
P2860
P304
P356
10.1165/RCMB.2011-0399RT
P577
2012-03-08T00:00:00Z